Clinical trial • Phase III • Neurology
NIO752 for Alzheimer's disease
Phase III trial of NIO752 for Alzheimer's disease. 37 participants.
Overview
- Trial Therapeutic Area
- Neurology
- Trial Disease
- Alzheimer's disease
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 12-07-2024
- First CTIS Authorization Date
- 02-08-2024
Trial design
Phase III trial in Finland, Sweden, France and others.
- Target Sample Size
- 37
- Trial Duration For Participant
- 1996
Recruitment
- Planned Sample Size
- 37
- Recruitment Window Months
- 65
Geography
- Total Number Of Sites
- 10
- Total Number Of Participants
- 37
Finland
- Earliest CTIS Part Ii Submission Date
- 26-07-2024
- Latest Decision Or Authorization Date
- 02-08-2024
- Processing Time Days
- 7
- Number Of Sites
- 2
- Number Of Participants
- 3
Sites
- Site Name
- Clinical Research Services Turku CRST Oy
- Department Name
- 1101 : Clinical Research Unit (Phase I)
- Contact Person Name
- Juha Rinne
- Contact Person Email
- juha.rinne@varha.fi
- Site Name
- University Of Eastern Finland
- Department Name
- 1102 : Institute of Clinical Medicine, Brain Research Unit
- Contact Person Name
- Sudhir Kurl
- Contact Person Email
- sudhir.kurl@uef.fi
Sweden
- Earliest CTIS Part Ii Submission Date
- 26-07-2024
- Latest Decision Or Authorization Date
- 02-08-2024
- Processing Time Days
- 7
- Number Of Sites
- 2
- Number Of Participants
- 6
Sites
- Site Name
- Region Skane Skanes Universitetssjukhus
- Department Name
- 1202 : Minneskliniken
- Contact Person Name
- Henrik Östlund
- Contact Person Email
- henrik.ostlund@skane.se
- Site Name
- Karolinska University Hospital
- Department Name
- 1201 : ME Åldrande Kognitiv Forskning
- Contact Person Name
- Anne Börjesson-Hanson
- Contact Person Email
- anne.borjesson-hanson@regionstockholm.se
France
- Earliest CTIS Part Ii Submission Date
- 26-07-2024
- Latest Decision Or Authorization Date
- 07-08-2024
- Processing Time Days
- 12
- Number Of Sites
- 3
- Number Of Participants
- 13
Sites
- Site Name
- Centre Hospitalier Universitaire De Toulouse
- Department Name
- 3000 : Département de Neurologie
- Contact Person Name
- Jérémie PARIENTE
- Contact Person Email
- pariente.j@chu-toulouse.fr
- Site Name
- Assistance Publique Hopitaux De Paris
- Department Name
- 3001 : département des maladies du système nerveux
- Contact Person Name
- Nicolas VILLAIN
- Contact Person Email
- nicolas.villain@aphp.fr
- Site Name
- Centre Hospitalier Universitaire De Lille
- Department Name
- 3002 : Centre Mémoire de Ressources et de Recherche
- Contact Person Name
- Adeline ROLLIN-SILLAIRE
- Contact Person Email
- Adeline.ROLLIN@chu-lille.fr
Spain
- Earliest CTIS Part Ii Submission Date
- 26-07-2024
- Latest Decision Or Authorization Date
- 06-08-2024
- Processing Time Days
- 11
- Number Of Sites
- 3
- Number Of Participants
- 15
Sites
- Site Name
- Hospital Universitario Dr Peset Aleixandre
- Department Name
- 2002:Neurología
- Contact Person Name
- Lamberto Landete Pascual
- Contact Person Email
- lamberto676@gmail.com
- Site Name
- Hospital De La Santa Creu I Sant Pau
- Department Name
- 2000:Neurología
- Contact Person Name
- Alberto Lleo Bisa
- Contact Person Email
- alleo@santpau.cat
- Site Name
- Hospital Clinic De Barcelona
- Department Name
- 2001:Neurología
- Contact Person Name
- Mircea Balasa
- Contact Person Email
- mbalasa@clinic.cat
Sponsor
Primary sponsor
- Full Name
- Novartis Pharma AG
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Switzerland
Investigational products
- Investigational Product Name
- NIO752
Related trials
Other published trials that may interest you.